Our Board

Mrs Jo Parfrey

Jo is an experienced and successful investment professional with more than 10 years in the private equity industry. A qualified accountant, ACA, by training, she has worked in the corporate finance departments of FTSE 100 and FTSE 250 companies.

Read more

Dr Simon Cook

Simon joined the Institute as a tenure-track group leader in 1997 and held a CRUK Senior Cancer Research Fellowship from 2000-2006.

Read more

Dr Karen Lewis

Karen studied for a degree in biology and PhD in microbiology. Before joining BBSRC, she worked in commercial research and development with both a small biotechnology company and a large corporate.

Read more

Derek Jones

Derek is Chief Executive of Babraham Research Campus Ltd (formerly Babraham Bioscience Technologies Ltd (BBT)), the company which manages and develops the Babraham Research Campus.

Read more

Becky Paxton

Becky is Chief Financial Officer. Having joined Babraham Research Campus Ltd (formerly BBT) in 2002, Becky is responsible for the finance, HR and health & safety functions of Babraham Research Campus Ltd.

Read more

Clive Stanway

Clive is an independent cancer drug discovery and development advisor. In addition to the Babraham Research Campus, Clive holds non-executive director positions at Atelerix Ltd and CytoSeek Ltd and serves on the scientific advisory boards of 4Bio Capital and ANGLE plc.

Read more

Alexander Hewitson

Alex is a highly experienced Chartered Engineer and Chartered Surveyor with over 20 years’ experience working in a variety of environments successfully delivering business critical projects and programmes; the last 13 years of which have been specialising within the life-sciences sector.

Read more

Charlie Foreman

Charlie is currently a Senior Strategic Advisor at Cambridge University Health Partners (CUHP), developing the funding pillar of the Life Sciences Strategy. He is also a Senior Advisor at Lazard, the world’s largest independent investment bank, having first joined Lazard as a Managing Director in December 2009, responsible for European Capital Markets Advisory.

Read more